Pleiotropy

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 31.10.2021

Dieser Artikel auf Deutsch

Synonym(s)

pleiotropic; Pleiotropism (e)

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

In human genetics, pleiotropy (from the Greek pleion, "more", and tropos, "path") refers to the phenomenon that occurs when a gene (pleiotropic gene) influences several, apparently unrelated phenotypic traits (trait expression) simultaneously.

For example, effects of cytokines on several different target cells/tissues are also referred to as pleiotropic (Avogaro A et al. 2018).

General informationThis section has been translated automatically.

A mutation in a pleiotropic gene can cause effects on different organs. For example, a mutation in the patched gene in nevoid basal cell carcinoma syndrome leads to numerous changes such as jaw cysts, hypertelorism, dimples on the palms of the hands and soles of the feet, etc.

Another example of pleiotropy is phenylketonuria (PKU). This disease causes mental retardation and decreased pigmentation of hair and skin. It can be caused by a variety of mutations in a gene on chromosome 12 that codes for the enzyme phenylalanine hydroxylase.

Phenylalanine hydroxylase converts the amino acid phenylalanine to tyrosine. Unconverted phenylalanine accumulates in the bloodstream and can lead to concentrations that are toxic to the developing nervous system of newborns and young children. Since the body uses tyrosine to make melanin, failure to convert normal levels of phenylalanine to tyrosine can result in light hair and skin.

LiteratureThis section has been translated automatically.

  1. Avogaro A et al (2018) The pleiotropic cardiovascular effects of dipeptidyl peptidase-4 inhibitors. Br J Clin Pharmacol 84:1686-1695.https://www.ncbi.nlm.nih.gov/pubmed/29667232
  2. Itin P (2018) Fundamentals of genetics. In: G Plewig G et al (ed.) Braun-Falco`s Dermatology, Venerology and Allergology. Springer Reference Medicine S 35-43

Authors

Last updated on: 31.10.2021